Phase I study of inhalation of interleukin-2 in patients with metastatic or unresectable cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-2 (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 22 May 2014 Biomarkers information updated
- 23 Sep 2005 New trial record.